4554.T
Fuji Pharma Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,755.00
−0.45%Aug 18, 2026, 09:02 UTC
Fuji Pharma announced on August 17 that it obtained manufacturing and marketing approval for four generic drug products of one ingredient, pomalidomide capsules, for relapsed or refractory multiple myeloma.
Source:Aug 12, 2026, 04:10 UTC
Fuji Pharma Co., Ltd. announced that it was certified as a DX Certified Business Operator by Japan's Ministry of Economy, Trade and Industry, effective August 1, 2026.
Source: